| 1EOL | date | ![]() |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||
| compound | source | ||||||||||||||
| symmetry |
| ||||||||||||||
| crystal cell |
| ||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||
| ligand | BBS, CPI, DOA, NLE | enzyme |
| ||||||||||||
| related structures | by homologous chain: 1EOJ, 1THP, 1THS | ||||||||||||||
| Gene Ontology |
| ||||||||||||||
| Primary reference | Design of P1' and P3' residues of trivalent thrombin inhibitors and their crystal structures., Slon-Usakiewicz JJ, Sivaraman J, Li Y, Cygler M, Konishi Y, Biochemistry 2000 Mar 7;39(9):2384-91. PMID:10694407 | ||||||||||||||
| Data retrieval |
![]() |
| View 1EOL in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |